Research progress in aldose reductase

Journal of Central South University (Medical Sciences)

Volumn 35, Issue 4, 2010, Pages 395-400

  Gu, Juan ^a   Yan, Jin ^a   Wu, Weihua ^a,b   Huang, Qi ^a   Ouyang, Dongsheng ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HUAIHUA MEDICAL COLLEGE   (China)

Author keywords

Activity; Aldose reductase; Diseases; Function; Inhibitor

Indexed keywords

ALDEHYDE REDUCTASE; DRUG DERIVATIVE; ENZYME INHIBITOR; EPALRESTAT; RHODANINE; THIAZOLIDINE DERIVATIVE;

ANIMAL; CELL PROLIFERATION; DIABETES MELLITUS; DRUG ANTAGONISM; ENZYMOLOGY; HUMAN; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ALDEHYDE REDUCTASE; ANIMALS; CELL PROLIFERATION; DIABETES COMPLICATIONS; ENZYME INHIBITORS; HUMANS; OXIDATIVE STRESS; RHODANINE; SIGNAL TRANSDUCTION; THIAZOLIDINES;

EID: 77952848952     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2010.04.021     Document Type: Review

References (46)

1. O'connor T, Ireland L S, Harrison D J, et al. Major differences exist in the function and tissue - specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members [J]. Biochem J, 1999, 343(2):487-504.
2. Lee K W Y, Ko B C B, Jiang Z, et al. Overexpression of aldose reductase in liver cancers may contribute to drug resistance[J]. Anti-Cancer Drugs, 2001, 12(2):129-132.
3. Lefrançois-Martinez A M, Bertherat J, Val P, et al. Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1 B1) is associated with malignancy in human sporadic adrenocortical tumors [J]. J Clin Endocrinol Metab, 2004, 89(6):3010-3019.
4. Anil Kumar P, Bhanuprakash Reddy G. Focus on Molecules: Aldose reductase [J]. Exper Eye Res, 2007, 85(6):739-740.
5. Wilson D K, Bohren K M, Gabbay K H, et al. An unlikely suger substrate site in the 1. 65 Å structure of the human aldose reductase holoenzyme lmplicated in diabetic complications [J]. Science, 1992, 257(5066):81-84.
6. Rondwau J M, Tete-Favier F, Podjamy A, et al. Novel NADPH-binding domain revealed by the crystal structure of aldose reductase [J]. Nature, 1992, 30(335):469-472.
7. Hers H G. The mechanism of the transformation of glucose in fructose in the seminal vesicles [J]. Biochim Biophys Acta, 1956, 22(1):202-203.
8. Burg M B, Kwon E D, Kultz D. Regulation of gene expression by hypertonicity [J]. Ann Rev Physiol, 1997, 59: 437-455.
9. Srivastava S, Chandra A, Bhatnagar A, et al. Ansari NH. Lipid peroxidation product, 4-hydroxynonenal and its conjugate with GSH are excellent substrates of bovine lens aldose reductase [J]. Biochem Biophys Res Commun, 1995, 217(3):741-746.
10. Vander Jagt D L, Kolb N S, Vander Jagt T J, et al. Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate [J]. Biochim Biophys Acta, 1995, 1249(2):117-126.
11. Srivastava S, Watowich S J, Petrash J M, et al. Structural and kinetic determinants of aldehyde reduction by aldose reductase[J]. Biochemistry, 1999, 38(1):42-54.
12. Ramana K V, Dixit B L, Srivastava S, et al. Selective recognition of glutathiolated aldehydes by aldose reductase [J]. Biochemistry, 2000, 39(40):12172-12180.
13. Bhatnagar A, Srivastava S K. Aldose reductase: congenial and injurious profiles of an enigmatic enzyme [J]. Biochem Med Metab Biol, 1992, 48(2):91-121.
14. Petrash J M, Harter T M, Murdock G L. A potential role for aldose reductase in steroid metabolism [J]. Adv Exp Med Biol, 1997, 414: 465-473.
15. Wermuth B, Monder C. Aldose and aldehyde reductase exhibit isocorticosteroid reductase activity [J]. Eur J Biochem, 1983, 131(2):423-426.
16. Srivastava S K, Hair G A, Das B, et al. activated and unactivated forms of human erythrocyte aldose reductase [J]. Proc Nad Acad Sci USA, 1985, 82(21):7222-7226. (Pubitemid 16193714)
17. Chandra A, Srivastava S, Petrash J M, et al. Active site modification of aldose reductase by nitric oxide donors [J]. Biochimica et Biophysica Acta, 1997, 1341(2):217-222. (Pubitemid 27451938)
18. Hwang Y C, Sato S, Tsai J Y, et al. Aldose reductase activation is a key component of myocardial response to ischemia [J]. FASEB J, 2002, 16(2):243-245.
19. Baba S P, Wetzelberger K, Hoetker J D, et al. Posttranslational glutathiolation of aldose reductase (AKR 1 B1) : A possible mechanism of protein recovery from S-nitrosylation [J]. Chem Biol Interact, 2009, 178 (1-3):250-258.
20. Chang K C, Paek K S, Kim H J, et al. Substrate-induced up-regulation of aldose reductase by methylglyoxal, a reactive oxoaldehyde elevated in diabetes [J]. Mol Pharmacol, 2002, 61(5):1184-1191.
21. Hontta N, Akanuma Y, Kawamori R, et al. Long-term clinical effects of epalrestart, an aldose reductase inhibitor, on diabetic peripheral neuropathy. The 3 - year, multicenter, comparative aldose reductase inibitor-diabetes complications trial [J]. Diabetes Care, 2006, 29(7):1538-1544.
22. Ramirez M A, Borja N L. Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy [J]. Pharmacotherapy, 2008, 28(5):646-655.
23. Hotta N, Toyota T, Matsuoka K, et al. Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 5 2-week multicenter placebo - controlled double - blind parallel group study [J]. Diabetes Care, 2001, 24(10):1776-1782.
24. Jung H A, Yoon N Y, Bae H J, et al. Inhibitory activities of the alkaloids from Coptidis Rhizoma against aldose reductase [J]. Arch Pharm Res, 2008, 31(11):1405-1412.
25. Fatmawati S, Kurashiki K, Takeno S, et al. The inhibitory effect on aldose reductase by an extract of Ganoderma lucidum [J]. Phytother Res, 2008, 23(1):28-32.
26. LÜ Lihua, LÜ Linhua, OUYANG Dongsheng. The study of twenty natural antihypertensive compound's aldose reductase inhibition [J]. Guiding Journal of Tradittonal Chinese Medicing and Pharmacy, 2008, 14(10):8-12.
27. Wang Y, Lee S C, So W Y, et al. Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes [J]. Diabetes Care, 2003, 26(8):2410-2415.
28. Kador P F. Contributions of Jin H. Kinoshita to aldose reductase research [J]. Exp Eye Res, 1990, 50(6):615-620.
29. Williamson J R, Chang K, Frangos M, et al. Hyperg ycemic pseudohypoxia and diabetic complications [J]. Diabetes, 1993, 42(6):801-813.
30. WU Jing, ZHONG Huiju, SUN Zhixiang, et al. Observation of therapeutic effect of breviscapine on diabetic peripheral neuropathy[J]. Bulletin of Hunan Medical University, 2002, 27(4):337-339.
31. LIU Changshan, ZHU Xixing. Initial observation of erythrocyte aldose reductase activity in Diabetes [J]. Chinese Journal of Diabetes, 1996, 4(4):198-201.
32. Ramana K V, Chandra D, Srivastava S, et al. Aldose reductase mediates mitogenic signaling in vascular smooth muscle cells[J]. J Biol Chem, 2002, 277(35):32063-32070.
33. OUYANG Dongsheng, HUANG Qi, LIU Li, et al. Role of aldose reductase in diabetic complications and angiocardiopathy [J]. China Journal of Modem Medicine, 2008, 18(17):2506-2509.
34. CHE Qi, JIANG Tao, UN Yifeng, et al. Effects of aldose reductase transection on the proliferation of rat mesangial cells in vitro [J]. Chinese Journal of Pathology, 2005, 34(7):417-420.
35. Papezizikova I, Pekarova M, Chatzopoulou M, et al. The effect of aldose reductase inhibition by JMC-2004 on hyperglycemia-induced endothelial dysfunction [J]. Neuro Endocrinol Lett, 2008, 29(5):775-778.
36. Vikramadithyan Ft K, Hu Y, Noh H L, et al. Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice [J]. J Clin Invest, 2005, 115(9):2434-2443.
37. Ramasamy R, Oates P J, Schaefer S. Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury [J]. Diabetes, 1997, 46(2):292-300.
38. ZHENG Chunhua, ZHOU Li, CHEN Yuan, et al. Aldose reductase inhibitor and blood vessel restenosis [J]. Chinese Journal of Hypertension, 2007, 15(8):651-655.
39. Srivastava S, Chandrasekar B, Bhatnagar A, et al. Lipid peroxidation-derived aldehydes and oxidative stress in the failing heart: role of aldose reductase [J]. Am J Physiol, 2002, 283: H2612-H2619.
40. Ruef J, Liu S Q, Bode C, et al. Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury [J]. Arterioscler Thromb Vasc Biol, 2000, 20: 1745-1752.
41. Liu X, Shen J, Zhan R, et al. Proteomic analysis of homocysteine induced proliferation of cultured neonatal rat vascular smooth muscle cells [J]. Biochim Biophys Acta, 2009, 1794(2):177-184.
42. Ananthakrishnan R, Kaneko M, Hwang Y C, et al. Aldose reductase mediates myocardial ischemia - reperfusion injury in part by opening mitochondrial permeability transition pore [J]. Am J Physiol Heart Circ Physiol, 2009, 296 (2):H333-H341.
43. Keith R J, Haberzettl P, Vladykovskaya E, et al. Aldose reductase decreases endoplasmic reticulum stress in ischemic hearts [J]. Chemico - Biological Interactions, 2009, 178 (1-3):242-249.
44. Srivatava S K, Ramana K V, Bhatnagar A. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options [J]. Endocr Rev, 2005, 26(3):380-392.
45. Kabututu Z, Manin M, Pointud J C, et al. Prostaglandin F2 | alpha | synthase activities of aldo-keto reductase 1B1, 1B3, 1B7[J]. J Biochem, 2009, 145(2):161-168.
46. Tammali R, Ramana K V, Singhal S S, et al. Aldose reductase regulated growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells[J]. Cancer Res, 2006, 66(19):9705-9713.